Asia Fresh News

Asia Fresh Stories

Archive for May 20th, 2016

Global Smartphone Sales Growth Driven by China

leave a comment »

NUREMBERG, Germany /PRNewswire/ —

  • Low-end smartphones continue to drive market volume growth
  • Increases in average selling price partially offset volume decline in the saturated Western Europemarket
  • China delivers strongest sales growth of 19 percent

Global demand for smartphones in 1Q 2016 remained positive, standing at six percent year-on-year. Thiswas helped by continued low-end segment growth in the majority of emerging regions, despite weak economies across the globe. Only China experienced strong growth (up 19 percent year-on-year), driven byincreased operator subsidies aimed at spurring 4G adoption.

Smartphone sales 1Q 2015 vs. 1Q 2016

Units sold (in mil.)

Sales value (in bn. US$)

Y/Y percent

Y/Y percent

1Q15

1Q16

change

1Q15

1Q16

change

Western Europe

31.8

30.0

-6%

12.5

11.9

-5%

Central & Eastern Europe

16.9

17.1

+1%

3.4

3.5

+3%

North America

43.5

45.4

+4%

17.3

18.1

+5%

Latin America

27.9

24.8

-11%

7.3

6.5

-11%

Middle East & Africa

39.9

42.0

+5%

11.1

10.4

-6%

China

92.0

109.2

+19%

27.3

32.1

+18%

Developed APAC

19.5

18.7

-4%

11.4

10.9

-4%

Emerging APAC

47.8

50.0

+5%

8.2

7.9

-4%

Global

319.3

337.2

+6%

98.5

101.3

+3%

Source: GfK Point of Sales (POS) Measurement data in 90+ markets, May 2016

Kevin Walsh, director of trends and forecasting at GfK comments, “Quarter one shows continued smartphone growth, however, we are seeing a slowdown in growth rates when we compare year-on-year performance. As a result, we have downgraded our 2016 growth forecast to five percent year-on-year. Operators and manufacturers are responding with a variety of strategies in the different regions, such as increased marketing activity and subsidies.”

North America: Aggressive operators drive growth in 1Q

In North America, smartphone demand returned to growth in 1Q 2016, following a dip in the last quarter of 2015. In total, 45.4 million units were sold, down 19 percent quarter-on-quarter and up four percent year-on-year. The rise in demand was helped by aggressive operator marketing and sales efforts.

However, there are signs that this will not continue at the same level because of the cost. In addition, consumer migration to 4G is in the last quartile of its adoption curve. Traditionally, that is when subscriber retention activities become more important than acquisition, lengthening smartphone replacement cycles.

Western Europe: Year-on-year demand falls for the first time as market saturation bites

30 million units were sold in Western Europe in 1Q 2016, a fall of 29 percent quarter-on-quarter and six percent year-on-year. Sales declined despite strong demand for the Samsung Galaxy S7 and S7 Edge in their first three weeks of launch.

Germany, the largest smartphone market in Western Europe, saw a significant fall in demand during this quarter of 11 percent year-on-year. Although GfK expects a slight recovery, it predicts total smartphone demand here will fall three percent year-on-year in 2016.

GfK forecasts a partial recovery in Western Europe in the second half of 2016, helped by the launch of the Apple iPhone 7. This launch could generate more of a sales uplift than 2015’s iPhone, buoyed by users who are 24 months on from the strong iPhone 6 and 6 Plus launch now looking to upgrade.

Central Europe: Positive outlook as Russia shows signs of recovery

Smartphone unit demand was at 17.1 million in 1Q 2016, down 24 percent quarter-on-quarter. While growth in demand within Poland has slowed since 4Q 2015’s strong performance, it appears to have stabilized in Russiafollowing poor results in 2015. The outlook for the region is therefore positive, with smartphone unit demand forecast to reach 77 million in 2016, a growth of five percent year-on-year.

Latin America: Smartphone demand suffers third consecutive quarterly decline

Smartphone demand in Latin America continued to decline in 1Q 2016 to 24.8 million units, a drop of 22 percent quarter-on-quarter and 11 percent year-on-year. The Brazilian economic and political situation is the major contributor to this decline, and even the Olympic Games are unlikely to provide a much-needed respite for the market.

In comparison, Argentina saw strong demand in 1Q 2016 as the economy finally started to show signs of a recovery. Overall, however, smartphone demand in the region will remain weak with 2016 posting a decline of 12 percent year-on-year. Looking at the region without Brazil, performance is more promising, up seven percent year-on-year.

Middle East and Africa: Macroeconomic weakness slows growth

Growth in the Middle East and Africa (MEA) slowed significantly to five percent year-on-year in 1Q, down from 12 percent growth in 4Q 2015 year-on-year. Falling oil prices in Saudi Arabia and Nigeria resulted in weak demand.

ASP in the region eroded considerably to US$247 (down 11 percent year-on-year). The main cause was a shift in demand to the sub-US$100 price band, which accounted for 26 percent of the total smartphone sales in the quarter, up from 22 percent in 1Q 2015.

GfK forecasts that MEA will post an increase of 12 percent year-on-year to 183 million units in 2016.

China: Strongest growth in demand for almost two years

Smartphone demand in China reached 109.2 million in 1Q 2016, up two percent quarter-on-quarter and 19 percent year-on-year. This is the strongest year-on-year growth in demand in two years.

The desire for 4G is behind the impressive growth, with 4G smartphone demand in 1Q 2016 up 58 percent year-on-year. Increased operator subsidy support and the falling cost of data plans have made 4G smartphones more attractive and affordable. More than 95 percent of smartphones sold in the first quarter of 2016 were 4G enabled.

Overall, total smartphone demand in China will be 411 million units in 2016, up seven percent year-on-year.

Developed Asia Pacific*: A tale of saturation and subsidies

In 1Q 2016, smartphone demand totalled 18.7 million units, down seven percent quarter-on-quarter and four percent year-on-year. However, it’s not all gloom in the region.

Japan saw a return to mild growth of one percent year-on-year in 1Q 2016. This was helped by a rush to buy smartphones under operator price promotions early in the quarter, ahead of the government-imposed restrictions on promotions announced for February. After these restrictions became effective in February, demand turned negative for the rest of the quarter. The outlook for 2016, though, is positive, and GfK forecasts growth of one percent.

This positive performance was more than offset by declines in other major countries, including S. Korea andAustralia. This was despite a strong performance from Samsung’s Galaxy S7 and S7 Edge, which launched in the quarter.

GfK expects demand to decline by eight percent year-on-year in 2016, due to a saturated smartphone market.

Emerging Asia Pacific*: Temporary slowdown in 1Q

Emerging Asia Pacific (APAC) was the powerhouse of smartphone growth throughout last year, but the region experienced a considerable drop in year-on-year growth, from 24 percent in 4Q 2015 to five percent in 1Q 2016.

This slow-down was caused by India, where demand was dampened by operators increasing data rates. GfK expects the impact to be temporary, because new operators set to enter the market later this year could ignite a local price war. The “Make in India” initiative is also likely to help keep prices down.

Price competition intensified further in 1Q 2016 in the key markets of India and Indonesia as local and Chinese vendors continued to offer cheaper smartphones. Despite this, smartphone penetration in the sub-US$100 price band remained at only 30 percent, leaving plenty of room for smartphone demand growth.

Smartphones: 2015 sales vs. 2016 forecast

Units sold (in mil.)

Sales value (in bn. US$)

2015

2016

Y/Y percent

2015

2016

Y/Y percent

Sales

forecast

change

sales

forecast

change

Western Europe

137.3

133.6

-3%

53.6

51.1

-5%

Central & Eastern Europe

73.4

77.1

+5%

14.8

14.7

-1%

North America

190.8

197.4

+3%

78.0

76.9

-1%

Latin America

110.3

97.2

-12%

27.1

23.4

-14%

Middle East & Africa

162.6

182.7

+12%

42.1

42.4

+1%

China

385.3

411.5

+7%

115.8

120.4

+4%

Developed APAC

73.5

67.3

-8%

43.1

38.4

-11%

Emerging APAC

201.1

229.5

+14%

32.9

33.4

+2%

Global

1,334.2

1,396.3

+5%

407.4

400.7

-2%

Source: GfK Point of Sales (POS) Measurement data in 90+ markets for calendar year 2015 and GfK forecasts for calendar year 2016, as at May 2016.

Arndt Polifke, global director of telecom products at GfK concludes, “The connected consumer is evolving from connectivity to complete and seamless integration with technology. For smartphones, there is still growth to come from connectivity, especially in the emerging markets. Already though, we are seeing how the next wave of growth from wearables, virtual reality and smart home can be complementary to smartphone growth in 2016 and beyond.”

Contact: Wes Rogers – T. +44-203-287-3262 / T. +1-912-506-0869 / wes@greenfieldscommunications.com

 

Source: GfK
Related Links:

Written by asiafreshnews

May 20, 2016 at 4:59 pm

Posted in Uncategorized

Bringing Innovation to Patients: Merck Presents New Advances at ASCO 2016

leave a comment »

DARMSTADT, Germany /PRNewswire/ —

Not intended for UK- or US-based media

ASCO Abstract #

Avelumab: 4009, TPS4134, TPS4135, 9036, TPS9105, 3055, TPS3106, 8503, 4514, 4516, 5533, TPS5600, TPS4580, 9508; tepotinib: 4072

  • Abstracts featuring Merck compounds span a broad range of cancers, with an emphasis on those which are difficult-to-treat and represent significantunmet patient need
  • Avelumab data in seven different cancers from rapidly accelerating JAVELIN clinical program to be presented

Merck, a leading science and technology company, announced that this year’s Annual Meeting of the American Society of Clinical Oncology (ASCO; June 3-7, 2016, Chicago, IL, U.S.) will feature research on Merck compounds across a broad range of cancers. These reports, which focus on cancers with significant unmet patient need, will inform and advance scientific knowledge within the oncology community. This includes data on avelumab*, Merck’s high priority, late-stage investigational immuno-therapy, that is being developed in collaboration with Pfizer.

(Logo: http://photos.prnewswire.com/prnh/20160518/369530LOGO )

“We have a clear and focused commitment to accelerate oncology innovation and transform the way cancer is treated, both by leveraging our internal expertise and capabilities, and through our collaborations,” said Luciano Rossetti, Executive Vice President, Head of Global Research & Development at the biopharma business of Merck. “Avelumab is an example of this strategy coming to life, as it was originally discovered by Merck and is being co-developed with Pfizer. More broadly, we will be presenting data across multiple tumor types at ASCO as we continue to advance our oncology and immuno-oncology pipeline.”

Collaborating to bring innovation to cancer patients

Merck and Pfizer are presenting avelumab data at this year’s congress that reflect the significant progress this alliance is making. This includes results from the pivotal, Phase II metastatic Merkel cell carcinoma trial which, taken together with data from other challenging tumors being evaluated in the JAVELIN clinical development program, supports efficacy and a favorable safety profile for avelumab. Avelumab, an investigational, fully human, anti-programmed death-ligand 1 (PD-L1) monoclonal antibody, has a dual mechanism of action that is believed to enable the immune system to find and attack cancer cells. Avelumab’s clinical program, one of the largest immuno-oncology development programs, now includes approximately 2,200 patients across more than 15 tumor types. Together, the two companies have initiated 30 ongoing monotherapy or combination therapy programs with avelumab, including nine pivotal studies.

Innovation: treatment and beyond

Erbitux® (cetuximab) and precision medicine remain a strategic priority for Merck. As a cornerstone of treatment in RAS wild-type mCRC and SCCHN, Merck is committed to exploring Erbitux as an ‘anchor’ treatment in combination with immuno-therapies in these indications. Erbitux also continues to captivate the interest of leading researchers and the medical community with more than 30 abstracts at ASCO, the majority from investigator-led studies.

Merck aims to improve patients’ experiences along their treatment journey by helping patients and physicians to make faster treatment decisions. Merck is the first pharmaceutical company to collaborate with multiple diagnostic companies to co-develop and commercialize innovative liquid biopsy RAS biomarker tests to determine which patients with mCRC would benefit from treatment with Erbitux. At ASCO, Merck’s partner Sysmex Inostics will be presenting new data demonstrating the value of the co-developed and commercialized liquid biopsy test, which received CE mark approval earlier this year.

Truly innovative pipeline

Following Merck’s strategic reassessment of its portfolio, there is significant potential with later-stage priority programs and Merck’s truly innovative early pipeline. Six out of seven of the current pipeline products in Phases I-III were discovered in Merck’s labs.

Data will be presented on another of these Merck-discovered compounds, tepotinib**, an investigational, highly selective, small molecule inhibitor of the c-Met receptor tyrosine kinase. The ASCO presentation will report on tepotinib’s clinical activity and tolerability in Asian patients with advanced hepatocellular carcinoma, a cancer in which there is a considerable need for new treatment options.

Through Merck’s Translational Innovation Platforms in oncology and immuno-oncology, the company is developing differentiated therapeutic drugs targeting distinct cancer hallmarks and multiple immune-system-mediated mechanisms. These include, among others, DNA repair, antibody drug conjugates, oncogenes, tumor antigens, T-cell therapies, and targeted cytokines and chemokines.

*Avelumab is the proposed nonproprietary name for the anti-PD-L1 mAb (also known as MSB0010718C).

**Tepotinib is the proposed nonproprietary name for the c-Met kinase inhibitor (also known as MSC2156119J).

Avelumab and tepotinib are under clinical investigation and have not been proven to be safe and effective. There is no guarantee any product will be approved in the sought-after indication by any health authority worldwide.

Notes to Editors

Accepted Merck-supported abstracts are listed below. In addition, a number of investigator-sponsored studies have been accepted, including several related to Erbitux and avelumab (not listed).

Avelumab

Title: Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced gastric or gastroesophageal junction cancer from the JAVELIN Solid Tumor Phase Ib trial: analysis of safety, clinical activity
Lead Author: C Chung
Abstract #: 4009
Presentation Date/Time (CDT): June 4 08:00-11:30
Session: Poster Session: Gastrointestinal (Noncolorectal) Cancer
Room/Details: Hall A (Poster Board: 1)

Title: Maintenance therapy with avelumab (MSB0010718C; anti-PD-L1) vs continuation of first-line chemotherapy in patients with unresectable, locally advanced or metastatic gastric cancer: the Phase III JAVELIN Gastric 100 trial
Lead Author: M Moehler
Abstract #: TPS4134
Presentation Date/Time (CDT): June 4 08:00-11:30
Session: Poster Session: Gastrointestinal (Noncolorectal) Cancer
Room/Details: Hall A (Poster Board: 124b)

Title: Avelumab (MSB0010718C; anti-PD-L1) + best supportive care (BSC) vs BSC ± chemotherapy as third-line treatment for patients with unresectable, recurrent, or metastatic gastric cancer: the Phase III JAVELIN Gastric 300 trial
Lead Author: Y-J Bang
Abstract #: TPS4135
Presentation Date/Time (CDT): June 4 08:00-11:30
Session: Poster Session: Gastrointestinal (Noncolorectal) Cancer
Room/Details: Hall A (Poster Board: 125a)

Title: Avelumab (MSB0010718C; anti-PD-L1) as a first-line treatment for patients with advanced NSCLC from the JAVELIN Solid Tumor Phase Ib trial: safety, clinical activity, and PD-L1 expression
Lead Author: C Verschraegen
Abstract #: 9036
Presentation Date/Time (CDT): June 4 08:00-11:30
Session: Poster Session: Lung Cancer-Non-Small Cell Metastatic
Room/Details: Hall A (Poster Board: 359)

Title: Avelumab (MSB0010718C; anti-PD-L1) vs platinum-based doublet as first-line treatment for metastatic or recurrent PD-L1-positive non-smallcell lung cancer: the Phase III JAVELIN Lung 100 trial
Lead Author: M Reck
Abstract #: TPS9105
Presentation Date/Time (CDT): June 4 08:00-11:30
Session: Poster Session: Lung Cancer-Non-Small Cell Metastatic
Room/Details: Hall A (Poster Board: 425a)

Title: Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced cancer: safety data from 1300 patients enrolled in the Phase Ib JAVELIN Solid Tumor trial
Lead Author: K Kelly
Abstract #: 3055
Presentation Date/Time (CDT): June 5 08:00-11:30
Session: Poster Session: Developmental Therapeutics-Immunotherapy
Room/Details: Hall A (Poster Board: 377)

Title: Avelumab (MSB0010718C; anti-PD-L1) in combination with other cancer immunotherapies in patients with advanced malignancies: the Phase Ib/II JAVELIN Medley study
Lead Author: A Ribas
Abstract #: TPS3106
Presentation Date/Time (CDT): June 5 08:00-11:30
Session: Poster Session: Developmental Therapeutics-Immunotherapy
Room/Details: Hall A (Poster Board: 422b)

Title: Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced unresectable mesothelioma from the JAVELIN Solid Tumor Phase Ib trial: safety, clinical activity, and PD-L1 expression
Lead Author: R Hassan
Abstract #: 8503
Presentation Date/Time (CDT): June 5 08:00-11:05
Session: Oral Abstract Session: Lung Cancer-Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Room/Details: Arie Crown Theater

Title: Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic urothelial carcinoma from the JAVELIN Solid Tumor Phase Ib trial: analysis of safety, clinical activity, and PD-L1 expression
Lead Author: A Apolo
Abstract #: 4514
Presentation Date/Time (CDT): June 6 13:00-16:30
Session: Poster Session: Genitourinary (Nonprostate) Cancer
Room/Details: Hall A (Poster Board: A137)

Title: Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced adrenocortical carcinoma from the JAVELIN Solid Tumor Phase Ib trial: safety and clinical activity
Lead Author: C Le Tourneau
Abstract #: 4516
Presentation Date/Time (CDT): June 6 13:00-16:30
Session: Poster Session: Genitourinary (Nonprostate) Cancer
Room/Details: Hall A (Poster Board: 138)

Title: Avelumab (MSB0010718C; anti-PD-L1) in patients with recurrent/refractory ovarian cancer from the JAVELIN Solid Tumor Phase Ib trial: safety and clinical activity
Lead Author: M Disis
Abstract #: 5533
Presentation Date/Time (CDT): June 6 13:00-16:30
Session: Poster Session: Gynecologic Cancer
Room/Details: Hall A (Poster Board: 356)

Title: Avelumab (MSB0010718C; anti-PD-L1) ± pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in patients with platinum-resistant/refractory ovarian cancer: the Phase III JAVELIN Ovarian 200 trial
Lead Author: E Pujade-Lauraine
Abstract #: TPS5600
Presentation Date/Time (CDT): June 6 13:00-16:30
Session: Poster Session: Gynecologic Cancer
Room/Details: Hall A (Poster Board: 421b)

Title: Avelumab (MSB0010718C; anti-PD-L1) in combination with axitinib as first-line treatment for patients with advanced renal cell carcinoma
Lead Author: J Larkin
Abstract #: TPS4580
Presentation Date/Time (CDT): June 6 13:00-16:30
Session: Poster Session: Genitourinary (Nonprostate) Cancer
Room/Details: Hall A (Poster Board: 199a)

Title: Avelumab (MSB0010718C; anti-PD-L1) in patients with metastatic Merkel cell carcinoma previously treated with chemotherapy: results of the Phase II JAVELIN Merkel 200 trial
Lead Author: H Kaufman
Abstract #: 9508
Presentation Date/Time (CDT): June 6 13:15-16:15
Session: Oral Abstract Session: Melanoma/Skin Cancers
Room/Details: Arie Crown Theater

Tepotinib

Title: Tolerability and activity of tepotinib in Asian patients with advanced hepatocellular carcinoma (HCC)
Lead Author: S Qin
Abstract #: 4072
Presentation Date/Time (CDT): June 4 08:00-11:30
Session: Poster Session: Gastrointestinal (Noncolorectal) Cancer
Room/Details: Hall A (Poster Board: 64)

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to http://www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.

About Avelumab

Avelumab (also known as MSB0010718C) is an investigational fully human anti-PD-L1 IgG1 monoclonal antibody. By inhibiting PD-L1 interactions, avelumab is thought to enable the activation of T-cells and the adaptive immune system. By retaining a native Fc-region, avelumab is thought to potentially engage the innate immune system and induce antibody-dependent cell-mediated cytotoxicity (ADCC). In November 2014, Merck and Pfizer announced a strategic alliance to co-develop and co-commercialize avelumab.

About Erbitux

Erbitux® is a highly active IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). As a monoclonal antibody, the mode of action of Erbitux is distinct from standard non-selective chemotherapy treatments in that it specifically targets and binds to the EGFR. This binding inhibits the activation of the receptor and the subsequent signal-transduction pathway, which results in reducing both the invasion of normal tissues by tumor cells and the spread of tumors to new sites. It is also believed to inhibit the ability of tumor cells to repair the damage caused by chemotherapy and radiotherapy and to inhibit the formation of new blood vessels inside tumors, which appears to lead to an overall suppression of tumor growth.

The most commonly reported side effect with Erbitux is an acne-like skin rash that seems to be correlated with a good response to therapy. In approximately 5% of patients, hypersensitivity reactions may occur during treatment with Erbitux; about half of these reactions are severe.

Erbitux has already obtained market authorization in over 90 countries world-wide for the treatment of colorectal cancer and for the treatment of squamous cell carcinoma of the head and neck (SCCHN). Merck licensed the right to market Erbitux outside the US and Canada from ImClone LLC, a wholly-owned subsidiary of Eli Lilly and Company, in 1998. Merck has an ongoing commitment to the advancement of oncology treatment and is currently investigating novel therapies in highly targeted areas.

About Tepotinib

Tepotinib (also known as MSC2156119J) is an investigational small-molecule inhibitor of the c-Met receptor tyrosine kinase capable of inhibiting both hepatocyte growth factor-dependent and -independent c-Met activation in low nanomolar concentrations. Alterations of the c-Met signaling pathway are found in various cancer types and correlate with aggressive tumor behavior and poor clinical prognosis. Tepotinib is currently under evaluation in Phase I/II trials.

About Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries.

Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Your Contact: Gangolf Schrimpf: +49-6151-72-9591

Source: Merck

Written by asiafreshnews

May 20, 2016 at 4:53 pm

Posted in Uncategorized

Xura Commissioned Heavy Reading Research Reveals 70 Percent of CSPs Plan to Virtualize Some or All of Their Messaging Platforms in the Next Four Years

leave a comment »

-Virtualization of SMS platforms the top priority for driving operational efficiency, and network scale and elasticity

WAKEFIELD, Mass. /PRNewswire/ — Today Xura, Inc. (NASDAQ: MESG), a leading provider of digital communications services, announced the findings of research that has revealed that 70 percent of communications service providers (CSPs) plan to virtualize some or all of their messaging platforms in the next four years.

The global research project, commissioned by Xura and carried out by Heavy Reading, assessed the progress, market timing, business and technical drivers, and challenges related to the virtualization of messaging services through the implementation of network functions virtualization (NFV).

Report author, Jim Hodges, senior analyst, commented, “What makes this level of commitment so profound is that it is driven by a broad range of technical and business drivers. For example, on the technical side, CSPs cite Operational Efficiency followed by Network Scale and Elasticity as the top two drivers, while on the business side CSPs are moving messaging solutions into the cloud to achieve not only Service Agility and Flexibility, but also Hardware Related Opex Reduction and Capex Reduction.”

The research found that the messaging services CSPs prioritized for migration to an NFV-based virtualized platform in 2016 were SMS (27%), followed by Spam/Fraud messaging control (22%), and then IP Messaging (21%).

David Spann, VP technology and architecture at Xura, said, “It’s clear that CSPs are looking to virtualize the services that are most heavily used – like SMS – on the network first and then align the launch of brand new services that may not yet be offered, like IP messaging, with deployments in NFV. Interestingly, those services like MMS that have probably taken the biggest hit from over-the-top (OTT) applications seem to be furthest down the priority list, with nearly a third (31%) saying they had no plans to virtualize this service as yet.”

Across the range of messaging platforms that CSPs were asked about, the most formidable NFV implementation challenges from a technical standpoint were product interworking, orchestration and migration complexity. They also ranked cultural challenges and business case definition as the top two business implementation challenges that their organizations face.

Spann added, “When you consider the impact on an organization’s culture that virtualization and the move to NFV will have, part of the issue will be with who has responsibility for the service implementation and delivery. Will it be the network team, the value added services team or the IT department; who manages the budget, the platform and the team that will have responsibility for running it on a day to day basis?”

Another key finding of the research was that there is no clear consensus over which cloud orchestration framework CSPs want NFV virtualized messaging applications to support. Over 40 percent of respondents indicated they wanted support for OpenStack – using integrated in-house contractors, telecom vendors or integrators – as well as VMware.

“OpenStack is gaining real credibility as a carrier grade framework in the market place, but given the continued demand for VMWare, and to a lesser extent Microsoft Azure (10%), it’s clear that solutions need to be agnostic in their support for different orchestration and virtualization environments,” commented Spann.

As already indicated though, orchestration is considered to be one of the biggest implementation challenges, and while over half (55%) of respondents said they would like to utilize a single management and orchestration (MANO) orchestrator, they also concede that this will be difficult.

On the concerns of CSPs with orchestration, Hodges said, “Orchestration is still an issue for commercial deployments and there is a concern that CSPs will be forced to deploying a number of vendor specific VNF orchestrators, which adds both cost and complexity into any virtualization migration.”

Spann added, “It will be interesting to see how the seven percent of respondents that are planning to use a single MANO orchestrator turn out, because they could set the template for where the rest of the industry moves to in the next few years.”

Hodges concluded, “The deployment of NFV will increasingly transform CSPs into cloud operators. By doing so it enables CSPs to go on the offensive with message service delivery, a capability they have lacked for a number of years. In the next four years, there will be a period of sustained activity that will see CSPs undertake the migration of many of their messaging services to the Cloud, to reap a whole range of benefits, and elegantly meet the perpetually evolving needs of their customers.”

To download the full research report, Virtualizing Messaging Services, please click here.

About Xura, Inc.

Xura, Inc (NASDAQ: MESG) offers a portfolio of digital services solutions that enable global communications across a variety of mobile devices and platforms. We help communication service providers (CSPs) and enterprises navigate and monetize the digital ecosystem to create innovative, new experiences through our cloud-based offerings. Our solutions touch more than three billion people through 350+ service providers and enterprises in 140+ countries.  You can find us at http://www.Xura.com.

Forward-Looking Statements

This press release includes “forward-looking statements.” Forward-looking statements include statements of plans and objectives for future operations, statements of future economic performance, and statements of assumptions relating thereto. In some cases, forward-looking statements can be identified by the use of terminology such as “may,” “expects,” “plans,” “anticipates,” “estimates,” “believes,” “potential,” “projects,” “forecasts,” “intends,” or the negative thereof or other comparable terminology. By their very nature, forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results, performance and the timing of events to differ materially from those anticipated, expressed or implied by the forward-looking statements in this press release. These risks and uncertainties discussed above, as well as others, are discussed in greater detail in our filings with the SEC. The documents and reports we file with the SEC are available through us, or our website, http://www.Xura.com, or through the SEC’s Electronic Data Gathering, Analysis, and Retrieval system (EDGAR) at http://www.sec.gov.

Source: Xura, Inc.

Related stocks: NASDAQ-NMS:MESG

Related Links:

Written by asiafreshnews

May 20, 2016 at 4:43 pm

Posted in Uncategorized

Telepizza Selects an Experienced QSR Operator as Its First Master Franchisee to Open the UK Market

leave a comment »

MADRID /PRNewswire/ —

  • Telepizza chooses “Karali Ventures LTD, as its first key master franchisee strategic partner who will open 80 stores in the UK
  • Telepizza strategy is to open a minimum of 300 stores in the UK in the next 10 years, with 20-30 regionalmaster franchisees

Telepizza, the largest non-U.S.-based pizza delivery company in the world by number of stores, is pleased to announce its first master franchisee partnership with Karali Ventures Limited in the UK, which will be opening 80 new stores within the next ten years. The first stores will be opened in late 2016.

(Logo: http://photos.prnewswire.com/prnh/20150317/735407-a)
(Photo: http://photos.prnewswire.com/prnh/20160519/369766)

Pablo Juantegui, Executive Chairman of Telepizza, welcomes Mr. Salim Janmohamed, Chairman & Managing Director at Karali Group, a group of companies specialised in the QSR industry, which is one of the largest Burger King operators in the UK and has developed other brands, including Chamama, Traditional Favourites, Caffé Italiano, and Cafe Select. The Group has an incredible track record of success over 30 years in the food and beverage business.

“We are very pleased to announce our first UK master franchisee partner, which marks an exciting step in our expansion into the UK market. Our international expansion is gaining momentum after a strong launch, which has been reinforced by international partners who are interested in growing our brand globally,” explained Pablo Juantegui, Executive Chairman of Telepizza.

Giorgio Minardi, President of International at Telepizza said: “We are very fortunate and pleased to have Mr. Salim Janmohamed join our organization. His impressive leadership and knowledge of the UK market will be instrumental for us to open up the market for our Brand and our other master franchisees.”

Plans to open 300 stores in the next 10 years

Telepizza plans to open a minimum of 300 stores, with 20-30 franchisees, that will develop 30 regional markets around the UK within the next ten years.

Telepizza supports every franchisee with its know-how, continued training and the solidity of its brand, acquired over almost three decades of operational excellence. Telepizza also safeguards quality standards, managing the entire process from factory to consumer.

Approximately 35% of Telepizza stores worldwide are owned and operated by Telepizza, while around 65% are owned by its business partners (franchises and master franchises)

Mr. Salim Janmohamed, Chairman & Managing Director at Karali Group said: “I am really looking forward to introducing Telepizza to the UK market and I am confident that the brand will receive a warm welcome using fresh ingredients in pizzas that are handmade on demand for the UK consumer, which is what is missing in the pizza delivery business.”

International strategy

Telepizza’s international strategy is focused on growth in markets where it is currently operating, exploring new business opportunities, and entering new markets via master franchises.

Currently, the company is present in 15 countries and its international chain sales exceed 30% of the total.

Note to Editors

Telepizza is the largest non-U.S.-based pizza delivery company in the world by number of stores. Headquartered inMadrid, the Company offers a variety of pizza and complementary products that combine consistent flavours across countries with a focus on local adaptation and innovation in the markets where it operates.

Telepizza operates in 15 countries with its own brand throughout Europe (Spain, Portugal and Poland), Latin America and other geographies mostly through master franchise agreements. As of December 2015, the company has a network of 1,311 stores (461 own stores and 850 franchised and master franchised stores) and employs a vertically-integrated business model throughout seven dough production facilities.

In 2015, the Group recorded €491.8 million in chain sales and €57.7 million in EBITDA.

Media contacts

Kreab  T. +34-917027170
Susana Sanjuán / ssanjuan@kreab.com / M. +34-677-946-805
Francisco Calderón / fcalderon@kreab.com / M. +34-654-642-160
Luis Meseguer / lmeseguer@kreab.com

Source: Telepizza
Related Links:

Written by asiafreshnews

May 20, 2016 at 4:37 pm

Posted in Uncategorized

HomeAway(R) gives travelers a chance to sleep in the Eiffel Tower for the first time

leave a comment »

PARIS /PRNewswire/ — HomeAway, the world leader in vacation rentals, is giving guests from around the globe a chance to make history as the first to ever to sleep over in the world’s most iconic landmark: the Eiffel Tower.

Experience the interactive Multimedia News Release here: http://www.multivu.com/players/English/7842251-homeaway-eiffel-tower/

Starting today, travelers can enter a contest at homeaway.com/eiffel-tower to win an extraordinary vacation this summer including the opportunity to stay in custom-built accommodation inside the Eiffel Tower by answering the question: What would you do if the HomeAway Eiffel Tower Apartment was all yours for a night?*

“For over a decade, HomeAway has brought loved ones together to create unforgettable experiences in whole home vacation rentals in more than 190 countries,” said Brian Sharples, co-founder and CEO of HomeAway. “Now we present this unprecedented Eiffel Tower history-making adventure, guaranteed to provide the most epic vacation memories of a lifetime.”

Four lucky winners from different corners of the world, along with up to five guests each, will sleep on the first level of Paris’ top real estate location. HomeAway’s Eiffel Tower Apartment, created by a Parisian designer just in time for the UEFA EURO 2016™ football tournament, will host the different groups on June 23, June 28, July 4, and July 8, 2016. The contest also includes three additional nights in Paris at a HomeAway vacation rental, round-trip transportation and a sumptuous gourmet dinner in HomeAway’s Eiffel Tower Apartment. Winners will be announced on June 10, the day the tournament kicks off in Paris.

“Creating a temporary dream vacation property inside this world-renowned monument reflects our company’s offering of private and comfortable accommodations perfect for making long-lasting vacation memories,” saidMariano Dima, chief marketing officer of HomeAway. “This concept is an extension of our ‘It’s Your Vacation, Why Share It?’ campaign that shows the benefits of whole home vacation rentals.”

HomeAway is a national sponsor in France and global official fan accommodations provider for UEFA EURO 2016™. From June 10-July 10, it will host tournament viewing parties and other free activities in the HomeAway Eiffel Tower Apartment for thousands to enjoy.

For more information visit: https://www.homeaway.com/info/media-center.

*The contest runs May 19-31, 2016 in the U.S., May 20-June 5 in Asia, and May 19-June 5, 2016 in Europe.

Media Contact:
Melanie Fish
+1 512-592-4431
mfish@homeaway.com

Source: HomeAway

Written by asiafreshnews

May 20, 2016 at 4:29 pm

Posted in Uncategorized

Mobile Commerce and Payments Company Mozido Names Scott Moore as General Manager of Asia-Pacific

leave a comment »

AUSTIN, Texas /PRNewswire/ — Mozido, a global provider of trusted digital commerce and payment solutions, today announced that Scott Moore has joined the company as General Manager of Asia-Pacific effective immediately.  Moore will be managing all Asia-Pacific operations, excluding China, from Mozido’s Asia headquarters in Singapore.

“Mozido is thrilled to have Scott join our company,” said Todd Bradley, CEO of Mozido. “His experience in building successful sales organizations, especially in the mobile financial services space and within markets like Asia, enables him to contribute immediately to Mozido’s success in delivering digital commerce and payment solutions globally using mobile phones.”

“I’m very excited to join Mozido and contribute to its rapidly expanding presence in the global payments and solutions market within Asia,” Moore said. “I share Mozido’s passion to improve lives by using mobile phones to bring an entirely new class of services in payments, remittances and greater financial control to the millions of individuals throughout Asia.”

Moore brings more than 20 years of financial services, banking and consulting experience.  Prior to joining Mozido, Scott was Asia-Pacific CEO of mobile commerce provider MPayMe Limited where he was instrumental in driving outstanding growth resulting in POWA’s 2014 acquisition of the company.  At POWA, Scott served as Head of Sales.  He has also held senior roles within Oracle, Eontec, and PricewaterhouseCoopers.  Moore holds a BA in Finance and Science from University of Sydney.

About Mozido
Mozido provides trusted digital payment and commerce solutions globally delivered as cost-effective cloud-based solutions branded for clients. Highly interoperable, Mozido solutions work with virtually any wireless carrier and mobile device, and integrate easily with ads, offers, and other products from third parties. Mozido’s worldwide presence and global offerings include operations in the US, China, India, Africa, Middle East, Europe and Latin America, enabling people to manage their money, payments and other services from their mobile phones. For more information, visit us at mozido.com. Follow us on Twitter: @Mozido.

Press Contact:
Van Leigh
SVP Marketing
Mozido
512-518-2200

Source: Mozido
Related Links:

Written by asiafreshnews

May 20, 2016 at 4:15 pm

Posted in Uncategorized

Hard Rock Hotels Throughout Asia Invite Guests to Turn Up Their Stay with the ‘Amplified’ Package

leave a comment »

SINGAPORE /PRNewswire/ — Hard Rock Hotels – with destinations from Bali to Pattaya andPenang to Singapore – invites guests to turn up their stay with the ‘Amplified’ package, available now throughDecember 31, 2016 at all Hard Rock Hotels worldwide, including:

Photo – http://photos.prnewswire.com/prnh/20160517/368679
Logo – http://photos.prnewswire.com/prnh/20160517/368695LOGO

The ‘Amplified’ package provides hotel guests with a memorable brand centric experience through direct engagement with offerings exclusive to Hard Rock Hotels. Recognized as the owners of the world’s largest music memorabilia collection with more than 80,000 legendary items, Hard Rock will offer guests who book the ‘Amplified’ package a behind the scenes look at the collection through a personalized, VIP memorabilia tour during their stay. As part of the brand’s signature The Sound of Your Stay® music amenity program, guests will also receive a pre-reserved Fender guitar, complete with floor amp and headphones for in-room jam sessions. In addition, guests will have the opportunity to take their memories home with a collectable pin and limited edition hat featuring the “I Got Plugged In @ Hard Rock Hotels” tagline.

Responding to the rising demand of travelers seeking personalized experiences, the ‘Amplified’ package allows for guests to tailor their stay by adding customized services to the package’s core offerings. During the booking process, guests are able to select extra services, such as booking a spa treatment at Rock Spa or acquiring tickets to a local event.

Guests are encouraged to share their amplified experience on Facebook, Twitter and Instagram by tagging @HardRockHotels and incorporating the #SoundOfMyStay hash tag for their chance to receive even more exclusive perks.   

With rates starting as low as USD$149.00, offerings vary per location. For a full list of Hard Rock Hotels featuring the ‘Amplified’ package, including rates and availability, please visit hardrockhotels.com/amplified.

Internationally recognized as a world-class entertainment and lifestyle brand, Hard Rock Hotels & Casinos offer stylish and contemporary design, unparalleled service and the thread that unites them all – music. Through music appreciation and an imaginative environment, Hard Rock Hotels & Casinos delivers products for the varied aspects of life – work, play and personal sanctuary. For more information or to book a stay at any Hard Rock Hotel, please visit www.hardrockhotels.com.

About Hard Rock International
With venues in 68 countries, including 164 cafes, 23 hotels and 11 casinos, Hard Rock International (HRI) is one of the most globally recognized companies. Beginning with an Eric Clapton guitar, Hard Rock owns the world’s greatest collection of music memorabilia, which is displayed at its locations around the globe. Hard Rock is also known for its collectible fashion and music-related merchandise, Hard Rock Live performance venues and an award-winning website. HRI owns the global trademark for all Hard Rock brands. The company owns, operates and franchises Cafes in iconic cities including London, New York, San Francisco, Sydney and Dubai. HRI also owns, licenses and/or manages hotel/casino properties worldwide. Destinations include the company’s two most successful Hotel and Casino properties in Tampa and Hollywood, Fl., both owned and operated by HRI parent company The Seminole Tribe of Florida, as well as other exciting locations including Bali, Chicago, Cancun, Ibiza,Las Vegas, Macau and San Diego. Upcoming new Hard Rock Cafe locations include San Juan, Reykjavik andLyon. New Hard Rock Hotel projects include Abu Dhabi, Atlanta, Berlin, Dubai, Itapema, Los Cabos, Tenerife, andShenzhen, Dalian and Haikou in China. For more information on Hard Rock International, visit www.hardrock.com.

For More Media Information:
Alycia Rea/Daniella DelaOsa
The Zimmerman Agency * 850.668.2222
Hardrock-PR@zimmerman.com

Source: Hard Rock International
Related Links:

Written by asiafreshnews

May 20, 2016 at 3:46 pm

Posted in Uncategorized

‘Build Your Own Laptop’ Pi-Top Kit Now In Stock at RS Components

leave a comment »

-Innovative pi-top development kit extends the functionality of the Raspberry Pi board to provide the ideal platform for makers and educators

HONG KONG  /PRNewswire/ — RS Components (RS), the trading brand of Electrocomponents plc (LSE:ECM), the global distributor for engineers, has announced that it is extending its portfolio of high-quality processor board development kits with the addition of the competitively priced pi-top ‘build your own laptop’ kit, which offers opportunities in the maker and educational arena helping users to ‘learn, play and create’. pi-top has now scaled up production of its crowd-funded kit, enabling RS to offer it for the first time.

'Build your own laptop' pi-top kit
‘Build your own laptop’ pi-top kit

 

'Build your own laptop' pi-top kit
‘Build your own laptop’ pi-top kit

 

The pi-top concept is essentially a Raspberry Pi powered laptop that is ideal for students to learn about programming, computing and hardware creation including electronics fabrication. It also teaches students transferable skills that will help them to create their own hacker and maker hardware projects. With no need for a soldering iron, the pi-top concept allows users to quickly start to experiment with electronics, create PCBs and produce 3D printing projects such as a pi-top case. This is facilitated through step-by-step online tutorials and lesson plans, and provides for collaborative learning and sharing with others in a cloud-based learning model.

The kit allows the building of a customised laptop with the addition of a Raspberry Pi board to provide the computing power. The kit comprises: a 13.3-inch HD LCD screen with eDP interface and 1366 x 768 resolution; a smart battery with more than 10 hours run time; a two-Wire SMBus V2.0 interface; a trackpad and fully programmable keyboard; an 8GB SD card with pre-installed pi-topOS; power supply; acrylic slice; and an image-based build manual.

The pi-top comes bundled with pi-topOS — the pi-top maker-based operating system — and other engaging educational software. The OS makes it easy to connect to Wi-Fi, monitor battery life and also personalise the OS. Also included on pi-topOS is CEEDUniverse, a game that teaches users how to code, build circuits and make hardware with their Raspberry Pi. Other features include: pi-topDASHBOARD – a real time code editor and lesson plan guide, which will have over 100 hours of tutorial content by summer 2016; kit component guide; plus all the features on Raspbian and other software including Python, Scratch, and Microsoft Office compatible software suite (Minecraft, Libre Writer, Libre Impress, and Libre Calc, Chromium, and 3D Slash).

The pi-top has been designed to be upgradeable and will work with all current and future versions of the Raspberry Pi. It is easy to swap out older boards for newer ones when released, meaning that users can upgrade their pi-top laptop for the price of a new Pi board. The pi-top laptop design was initially developed using the DesignSpark PCB and DesignSpark Mechanical design tools from RS. In particular, the use of DesignSpark PCB helped pi-top overcome the challenge of enabling the Raspberry Pi to use a 13.3inch high-definition laptop screen.

The pi-top is shipped from RS in grey and green variants with UK, EU and US power supply options available.

About RS Components

RS Components and Allied Electronics are the trading brands of Electrocomponents plc, the global distributor for engineers. With operations in 32 countries, we offer more than 500,000 products through the internet, catalogues and at trade counters to over one million customers, shipping around 44,000 parcels a day. Our products, sourced from 2,500 leading suppliers, include electronic components, electrical, automation and control, and test and measurement equipment, and engineering tools and consumables.

Electrocomponents is listed on the London Stock Exchange and in the last financial year ended 31 March 2015had revenues of GBP1.27bn.

For more information, please visit the website at www.hken.rs-online.com.

Editorial Contacts:                                                            

Vivian Zee
Public Relations & Advertising Manager
RS Components
vivian.zee@rs-components.com
+852 2610 6472

Matthew Keefe
Customer Marketing Manager
RS Components
matthew.keefe@rs-components.com
+852 2610 6476

Further information is available via these links:

Twitter: @RSComponents; @alliedelec; @designsparkRS

RS Components on Linkedin
http://www.linkedin.com/company/rs-components

Relevant Links:

Electrocomponents plc
www.electrocomponents.com

RS Components
www.rs-online.com

DesignSpark
http://www.designspark.com

Photo – http://photos.prnasia.com/prnh/20160519/8521603245-a
Photo – http://photos.prnasia.com/prnh/20160519/8521603245-b
Logo – http://photos.prnasia.com/prnh/20150818/8521505364LOGO

Source: RS Components

Related stocks: LSE:ECM OTC-PINK:EENEY

Written by asiafreshnews

May 20, 2016 at 3:24 pm

Posted in Uncategorized

Nial Fuller Wins Million Dollar Trading Competition

leave a comment »

-Renowned trader Nial Fuller has won the $1 million top prize in one of the world’s most lucrative trading competitions. Fuller ended the Million Dollar Trader Competition with an impressive 369% return on investment.

GOLD COAST, Australia /PRNewswire/ — Nial Fuller, a professional trader and renowned trading coach who has trained more than 15,000 students has won the $1 million top prize in one of the world’s most lucrative trading competitions.

Fuller, who has been trading since 2002, ended the Million Dollar Trader Competition with an impressive 369% return on investment. Participants competed over a 3 month period between February – April 2016.

“It was a tough competition and there were volatile market conditions during the 3 months of trading. Winning the competition was a balance of finding quality trading opportunities, applying sophisticated money management and having the discipline not to trade and risk giving up the lead,” Fuller said.

Fuller taught himself to trade during his senior high school years, originally taking an interest in the stock market and quickly moving into derivatives, futures, forex and other leveraged products.

He won the $1 million trading competition using his own proprietary trading strategy based on price action analysis.

“I’m a firm believer in keeping things simple and that is true with my trading style and strategy,” Fuller said.

“I’ve been trading with price action strategies for most of my trading career and these are the exact same strategies I’ve been teaching to other traders,” he added.

Fuller, who advocates a less is more approach, only traded a handful of times during the competition, mainly taking positions on major FX Pairs, Commodities & Indices.

There were several stand out trades where he continued to add to winning positions as the market trended, a money management concept known to traders as pyramiding.

“I’m not a day trader, I’m more of a swing trader, so I only traded a handful of times during the competition,” Fuller said.

“Being a competition, I knew I would need to take some risks and I tweaked my money management plan accordingly. Whenever possible, I aggressively pyramided into winning positions during trending moves, effectively snowballing the trade’s initial position size into a larger position size which substantially increased the risk reward ratio on each trade.”

About Nial Fuller

Nial Fuller is CEO and founder of Learn To Trade The Market, a global leader in professional trading education and training. His trading education service has taught more than 15,000 students since 2008. Nial is an avid blogger, author and market analyst. He currently actively manages his own portfolio.

For more information, please contact Nial Fuller on:

Email Or Phone via: http://www.learntotradethemarket.com/contact

Twitter:  https://twitter.com/NialFuller

Facebook: https://www.facebook.com/learntotradethemarket/

LinkedIn: https://www.linkedin.com/in/nialfuller

This content was issued through the press release distribution service at Newswire.com. For more info visit:http://www.newswire.com

Photo – http://photos.prnewswire.com/prnh/20160517/368792

Source: Learn To Trade The Market

Written by asiafreshnews

May 20, 2016 at 3:10 pm

Posted in Uncategorized

Universiti Utara Malaysia Named the Best Eminent Management University in Malaysia by Global Brands Magazine for the Year 2016

leave a comment »

LONDON /PRNewswire/ — The Global Brands Magazine awards, among the world’s most recognized branding awards, announced Universiti Utara Malaysia as the winner of Best Eminent Management University in Malaysia for the year 2016. The awards recognize the university’s excellence in setting a benchmark in offering studies in the field of business and management.

(Logo: http://photos.prnewswire.com/prnh/20160518/369255LOGO)

Global Brands Awards’ honours educational institutes who have set a benchmark for excellence and responded to changes quickly. The universities evaluated were awarded this honour for their exceptional commitment to excellence, branding, performance and providing a robust educational environment in their region. The data was collected and reviewed by an independent external agency to provide complete robustness to the study conducted.

The annual Global Brands Magazine awards celebrate the best-in-class brands, and Universiti Utara Malaysia received plaudits for its excellence and branding activities last year. The award aims to identify, create awareness about the significant economic value added by the institute and reward their performance with the ultimate global recognition.

Jay Reddy, head of branding at Global Brands Magazine said, This year alone, we have evaluated more than 250 universities worldwide. Since its inception in 1984, UUM has cemented its position as a leading institute among its excellent peers. This recognition is testament to the world-class learning environment and the high quality teaching with a constant output of world-class research. Many congratulations to Universti Utara Malaysia for building a highly impressive brand that excels in every area – growth and leadership.”

About Global Brand Awards:

Global Brands Awards was established with the aim of honouring excellence in performance and rewarding Companies across different sectors. The award honours companies who have performed extraordinarily well in the field of finance, education, hospitality, automobiles, lifestyle, and real estate and technology. The awards are given to acknowledge key players who strive for fineness and provide a platform for recognition.

More than 5000 Companies were evaluated as a part of the recent study conducted.  

About University Utara Malaysia:

Universiti Utara Malaysia (UUM), which was officially established on 16 February 1984, is the sixth Malaysian public university. It is the only university that was set up to specialise solely in management education from the very beginning of its establishment.

Contact:
Edwin Martin
info@gbrandsmag.com
+44 20 8133 3475

Source: Global Brands Publications Limited

Written by asiafreshnews

May 20, 2016 at 3:05 pm

Posted in Uncategorized